# Serial Plasma EBV DNA for Nasopharyngeal Carcinoma

> **NCT02476669** · — · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 900 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02476669
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476669, "Serial Plasma EBV DNA for Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02476669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*